Surmodics, Inc. (SRDX)

Surmodics Revenue

Surmodics had revenue of $29.57M in the quarter ending June 30, 2025, a decrease of -2.55%. This brings the company's total for the last twelve months to $120.80M, down -0.02% year-over-year. In the fiscal year ending September 30, 2024, Surmodics had annual revenue of $126.08M, down -4.91%.

• Revenue (ttm): $120.80M
• Revenue Growth: -0.02%
• P/S Ratio: 5.07
• Revenue / Employee: $310,542
• Employees: 389
• Market Cap: 614.51M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

• Medical Device 97.51M 77.3%
• In Vitro Diagnostics 28.57M 22.7%

By Geography

• United States 104.64M 83.0%
• Foreign 21.43M 17.0%

Fiscal year ended Sep 30, 2024 See the full Surmodics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	126.08M	-6.51M	-4.91%
Sep 30, 2023	132.58M	32.63M	32.65%
Sep 30, 2022	99.95M	-5.19M	-4.93%
Sep 30, 2021	105.14M	10.27M	10.83%
Sep 30, 2020	94.86M	-5.21M	-5.21%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error